Pfizer Agrees To Grant Drugmakers License To Make COVID-19 Antiviral In Lower-Income Countries

The New York Times (11/16, Nolen, Robbins) reports, “Pfizer announced a deal on Tuesday to allow its promising Covid-19 treatment to be made and sold inexpensively in 95 poorer nations that are home to more than half of the world’s population.” The deal “...